Jan Snoeys

5PUBLICATIONS
47CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 30, 2026
A phase 1, first-in-human study of safimaltib, a MALT1 inhibitor, in B-lymphocytic malignancies.

|Mar 15, 2020
Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines.

Ruben Boon, Manoj Kumar, Tine Tricot

|Feb 21, 2020
Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation.

Emma Hernandez-Sanabria, Evelien Heiremans, Marta Calatayud Arroyo

|Nov 22, 2019
Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.

Richard J Weaver, Eric A Blomme, Amy E Chadwick

|Nov 30, 2016
Elucidating the Plasma and Liver Pharmacokinetics of Simeprevir in Special Populations Using Physiologically Based Pharmacokinetic Modelling.

Jan Snoeys, Maria Beumont, Mario Monshouwer

Pageof 1

Frequent Collaborators

1 joint publications

Richard J Weaver

1 joint publications

Magnus Ingelman-Sundberg

1 joint publications

Paul Morgan

1 joint publications

Dominic P Williams